Deep-pocketed investors have adopted a bullish approach towards Align Tech (NASDAQ:ALGN), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga ...
On our call today, I'll provide an overview of our fourth quarter and full year 2025 results and discuss the performance of ...
Analysts' ratings for Align Tech (NASDAQ:ALGN) over the last quarter vary from bullish to bearish, as provided by 7 analysts. The following table encapsulates their recent ratings, offering a glimpse ...
Stifel Nicolaus analyst Jonathan Block assigned a Buy rating to Align Tech (ALGN – Research Report) today and set a price target of $275.00. The company’s shares closed yesterday at $228.00. According ...
In a report released today, Jason Bednar from Piper Sandler maintained a Buy rating on Align Tech (ALGN – Research Report), with a price target of $275.00. The company’s shares closed yesterday at ...
TEMPE, Ariz.--(BUSINESS WIRE)-- Align Technology, Inc. (ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign ® System of clear aligners, iTero™ intraoral ...
TEMPE, Ariz.--(BUSINESS WIRE)-- Align Technology, Inc. (ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign ® System of clear aligners, iTero™ intraoral ...
UBS analyst Kevin Caliendo reiterated a Hold rating on Align Tech yesterday and set a price target of $175.00. Caliendo covers the Healthcare sector, focusing on stocks such as Cencora, CVS Health, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results